VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis B
December 06, 2018 08:00 ET
|
VBI Vaccines, Inc.
Upon closing, VBI received gross proceeds of $11 million, consisting of an upfront payment and an equity investment at $3.05 per share from Brii BiosciencesVBI is eligible to receive an additional...
GeoVax and Leidos Enter into a Collaboration Agreement on Immunotherapy Research Program
November 19, 2018 09:00 ET
|
GeoVax, Inc.
Combined Technologies May Yield Therapies for Multiple Cancer Indications ATLANTA, GA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology...
Ormat and Toshiba Sign Strategic Collaboration Agreement
October 14, 2015 13:00 ET
|
Ormat Technologies, Inc.
RENO, Nev., Oct. 14, 2015 (GLOBE NEWSWIRE) -- and TOKYO, Oct. 15, 2015 -- Ormat Technologies Inc. (NYSE:ORA) and Toshiba Corporation (TOKYO:6502) announced today that the two companies have...